DATE: November 1, 2017
TIME: 9:00am PT, 12:00pm ET
Over 1.6 million people are diagnosed with sepsis in the U.S. each year1 and sepsis is the #1 cost of hospitalization (over $24 billion each year)1. Having a biomarker that can quickly identify sepsis is critical because mortality increases 8% every hour that treatment is delayed1.
Procalcitonin (PCT) helps determine if the patient has a bacterial infection (sepsis), the severity of the infection and is the patient responding to therapy2. PCT is a more accurate diagnostic parameter for sepsis and a better predictor of mortality and a more reliable marker than other biomarkers3. PCT also provides clinicians a mechanism for antibiotic stewardship2.
1. Sepsis Alliance Website: http://www.sepsis.org/downloads/2017_sepsis_facts_media.pdf3
2. Thermo Scientific B-R-A-H-M-S PCT Improving infection management.
3. Shiferaw, et al. The Role of Procalcitonin as a Biomarker in Sepsis. J Infect Dis Epidemiology. 2016;2:006 Vol 2.